Fentanyl (Illicit and Pharmaceutical): Dependence, Withdrawal, and Recovery Support

Fentanyl is a synthetic opioid that the DEA describes as "approximately 100 times more potent than morphine and 50 times more potent as a heroin analgesic" (DEA). Synthetic opioids other than methadone, a category that "primarily reflects illegally made fentanyl," were involved in about 69 percent of all overdose deaths in 2023 (CDC, 2025). It is hard to stop for two reasons: the drug is short-acting, so withdrawal arrives within hours, and almost everything sold as heroin or oxycodone now contains it, so there is no gentler version to step down to. This page covers dependence, withdrawal, medication treatment and why starting it can be tricky, testing, and how support at home fits once a prescriber is involved.

What fentanyl is and how it works

Pharmaceutical fentanyl is a Schedule II controlled substance (DEA Diversion Control, 2025). It comes as the Duragesic patch, the Actiq lozenge, and the Sublimaze injection used in surgery. The patch is labeled "only in opioid tolerant patients because of the risk for respiratory depression and death" (Duragesic prescribing information, 2018).

Illicitly manufactured fentanyl is the same molecule in a different product. The DEA notes it "is often found in powders or fake prescription pills that may be sold as fentanyl or as other opioids like heroin or oxycodone" (DEA). The DEA lists street names like "China Girl," "Jackpot," and "Murder 8" (DEA); most members say "fetty," "blues," or "M30s," after the pale blue counterfeit oxycodone tablets. The CDC notes that "Powdered fentanyl looks just like many other drugs and can be mixed with drugs like heroin, cocaine, and methamphetamine," and that it is increasingly pressed into pills resembling oxycodone or Xanax (CDC).

The DEA considers 2 mg "a potentially deadly dose" (DEA, One Pill Can Kill). Its laboratory profiling of tablets seized in 2023 found that "The average tablet contained 2.3 mg of fentanyl with a range of 0.1 to 7.0 mg/tablet," and that 67 percent of tablets quantitated held at least 2 mg (DEA Fentanyl Profiling Program, CY 2023). The agency's public figure is that "5 out of every 10 pills with fentanyl contain a potentially lethal dose" (DEA, 2025), and in 2025 it seized more than 47 million such pills (DEA).

The injectable label gives a terminal elimination half-life of 219 minutes and notes that it "accumulates in skeletal muscle and fat, and is released slowly into the blood" (fentanyl citrate injection prescribing information, 2025). A single dose fades in hours, so daily users dose many times a day and wake up in withdrawal, yet the drug also builds up in tissue, which is why it can take a week to clear and why starting buprenorphine has become harder.

Dependence, misuse, and addiction are not the same thing

The Duragesic label describes physical dependence as the state that "results in withdrawal symptoms after abrupt discontinuation or a significant dosage reduction of a drug" (section 9.3). A hospice patient on a patch is dependent. So is someone who thought they were buying Percocet for six months. It says nothing about who you are.

Misuse is using fentanyl in a way it was not prescribed, or using a street product at all, and many people who misuse it never chose it; the supply changed underneath them. Addiction, in clinical language an opioid use disorder, is the pattern of continuing despite harm: overdoses that did not change anything, money and relationships spent on staying out of withdrawal, a schedule the drug runs. SAMHSA is direct about what a week of detox and resolve produces: "most patients with OUD who undergo medically supervised withdrawal will start using opioids again and won't continue in recommended care" (SAMHSA TIP 63, Part 1). That is pharmacology, not effort.

Signs fentanyl has become a problem

What families describe to us usually sounds like this. Someone who used to "take a pill now and then" now needs one first thing in the morning and gets sick, sweaty, and irritable without it. Pinpoint pupils, nodding off mid-sentence, breathing slow enough to scare someone in the room. Burned foil, blue tablet fragments, empty baggies. Skin wounds that will not heal, a sign of xylazine. An opioid-type overdose in someone who swears they only use cocaine or Adderall, because fentanyl is mixed into stimulants too (CDC). And the one we hear most: a person who wants to stop, has tried more than once, and cannot get through the second day. Any one of these deserves a conversation. Two or more, plus any overdose, deserve a call today.

Why stopping fentanyl is rarely the dangerous part

Fentanyl withdrawal is miserable, and it is miserable fast. But the World Health Organization is clear that "opioid withdrawal is not usually life-threatening" (WHO, 2009). The danger sits on the far side of it; the same guidance says "All opioid dependent patients who have withdrawn from opioids should be advised that they are at increased risk of overdose due to reduced opioid tolerance." SAMHSA's overdose toolkit lists "using drugs after a recent period of abstinence, which may decrease previous tolerance levels" among the leading risk factors for a fatal overdose (SAMHSA, 2023).

With heroin, a person who lost tolerance and went back to the old amount was in danger. With fentanyl, one pill of unknown strength decides. The American Society of Addiction Medicine says withdrawal management "on its own, without ongoing treatment for opioid use disorder, is not a treatment method for opioid use disorder and is not recommended" (ASAM, 2020). Surviving withdrawal was never the goal of a plan. Surviving the month after it is.

Xylazine, a veterinary sedative, is now the top adulterant in fentanyl powder (DEA, 2025), and "Naloxone will not reverse the effects of xylazine" (CDC, 2024). We cover that combination on our page about tranq (xylazine).

Fentanyl withdrawal timeline

Everyone differs with dose, duration, xylazine, and whether medication is started. The general pattern follows, anchored to what the WHO says about short-acting opioids: symptoms begin "8-24 hours after last use; duration 4-10 days" (WHO). Fentanyl sits at the early end for onset and, for heavy daily users, past the late end for duration.

First 6 to 12 hours

For someone dosing many times a day, the first signs arrive within hours: yawning, watery eyes, runny nose, sweating, restless legs, anxiety, dread. This interval is what keeps people using through the night.

Days 1 to 3

The peak for most people. Muscle and bone aches, stomach cramps, vomiting, diarrhea, chills alternating with sweats, goosebumps, insomnia, a heart that will not slow down. Nobody dies of this, but the misery is why "just a little to take the edge off" happens on day two.

Days 4 to 10

The gut settles and the aches fade. Sleep stays broken and energy is low. For heavy users this stretch drags, because stored drug is still leaving; one hospital study noted that "terminal kidney clearance of fentanyl takes an average of 7 days for individuals with OUD and may be slower for people with higher BMI" (Thakrar et al., JAMA Network Open, 2024).

Weeks 2 and beyond

Physical symptoms are mostly gone. What remains is flat mood, anxiety, poor sleep, and cravings tied to people, places, and times of day, and tolerance has now dropped far enough that a return to the old dose is a life-or-death event.

How treatment works

The standard of care is medication. SAMHSA reports that "methadone, extended-release injectable naltrexone (XR-NTX), and buprenorphine were each found to be more effective in reducing illicit opioid use than no medication," and warns that "Arbitrary time limits on the duration of treatment with OUD medication are inadvisable" (SAMHSA TIP 63, Part 1). Methadone is dispensed daily through an opioid treatment program; buprenorphine (Suboxone and generics) can be prescribed by telehealth; naltrexone requires a full washout first.

Most of our members end up on buprenorphine, and fentanyl has made starting it harder. Buprenorphine is "a partial agonist at the mu-opioid receptor" (Suboxone prescribing information, section 12.1) with a very strong grip on that receptor. TIP 63 explains that this lets it "displace full agonists from receptors, precipitating opioid withdrawal," and that "The higher the level of physical dependence, the higher the likelihood of precipitating withdrawal" (SAMHSA TIP 63, Chapter 3D). That is the whole timeline above arriving in an hour. The Suboxone label says to start "when objective and clear signs of withdrawal are evident" (section 2.3); TIP 63's traditional benchmarks are the first dose "at least 12 hours after last use," with "a COWS score of 12 or higher" typically adequate (Chapter 3D).

Those benchmarks were written for heroin. With fentanyl leaking back out of fat, a person can look fully in withdrawal and still carry enough drug to be thrown into precipitated withdrawal. Of 123 hospitalized patients with confirmed fentanyl exposure who started buprenorphine, "20 (16.3%) developed PW" (Thakrar et al., 2024). Prescribers have responded with longer waits, tiny first doses built up over days (a "low-dose" induction), or larger first doses under hospital observation. Tell the prescriber it was fentanyl, be honest about when you last used, and do not start buprenorphine from a friend's supply. A bad induction is the most common reason we hear "Suboxone didn't work for me."

Naloxone is the other half of treatment. Narcan 4 mg nasal spray has been sold without a prescription since March 29, 2023, and the FDA calls it "the standard treatment for opioid overdose" (FDA, 2023). SAMHSA's toolkit says to "Wait 2-3 minutes before giving a second dose" if there is no response (SAMHSA), so keep two doses within reach. Fentanyl test strips are the third tool. The CDC notes they "are inexpensive and typically give results within 5 minutes," with the caveat that they "might not detect more potent fentanyl-like drugs, like carfentanil" (CDC). A strip does not make a pill safe.

Fentanyl with alcohol, benzodiazepines, or other drugs

The boxed warning on every fentanyl product reads the same way: "Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death" (Duragesic prescribing information, boxed warning). There is no room for a second sedative, and DEA labs found xylazine in 21 percent of fentanyl powder and 8 percent of tablets in 2023 (DEA), so many people are already taking two sedatives without knowing it.

Stimulants are the other combination that kills. People who use cocaine or methamphetamine and never touch opioids are dying of fentanyl mixed into their supply; someone with no opioid tolerance is exactly who 2 mg kills. As the CDC puts it, "you wouldn't be able to see it, taste it, or smell it" (CDC, 2024). If anyone in your house uses any illicit drug, naloxone belongs in the house.

Drug testing for fentanyl

A standard "opiates" screen does not catch it. The American College of Medical Toxicology says that "Separate assays are required to reliably detect buprenorphine, fentanyl, fentanyl analogs, hydrocodone, methadone, compounds in kratom, tramadol, oxycodone, U-47700, or other semisynthetic or synthetic opioids," and that "a negative test result on an immunoassay not specific for fentanyl cannot be used to exclude fentanyl or opioid exposure or intoxication" (ACMT, 2021). Even fentanyl immunoassays "detect many, but not all, fentanyl analogs."

Detection depends on how much and how long someone used. After a patch is removed, blood levels fall "about 50% in approximately 20-27 hours" (Duragesic, section 12.3). With months of daily street use, the drug stored in fat can keep urine positive for a week or longer (Thakrar et al., 2024). Saliva windows for fentanyl are less well established than urine windows and vary with the lab's cutoff, so we would rather not quote a single number. A fentanyl-specific assay, confirmed by a lab, is what reliably detects recent use.

Our members use at-home saliva screening assigned at random through the week. For fentanyl we use lab-confirmed testing rather than an instant strip: the sample goes to the lab, which runs a fentanyl-specific assay, so a result means something. If you are tested anywhere else, ask whether fentanyl is on the panel and whether positives are lab-confirmed. You do not choose whether you test; you choose who sees the results. For most members that means the prescriber and, if they want, a partner or parent. Someone on buprenorphine will test positive for buprenorphine, which is expected; what matters is whether the result matches the plan. We explain the details in our guide to how sobriety monitoring works.

How recovery from fentanyl works with Accountable

We are not a detox and we do not prescribe; the buprenorphine or methadone belongs to your doctor. What we provide is the support around it, at home, for as long as you need it.

1. Get the full picture

In the first sessions your coach maps what is actually going on: how much and how often, pills or powder, overdoses, wounds, and whether alcohol, benzodiazepines, or stimulants are in the picture. If you do not have a prescriber who understands fentanyl inductions, we help you find one, and with your permission we coordinate so everyone works from the same plan. Naloxone goes in the house before anything else.

2. Build a plan that fits your life

A plan that requires you to disappear for a month is one you will abandon. Your coach helps you plan around the real calendar: the hours before a first buprenorphine dose, the old contact texting at 11 p.m., the day of the week that has always been hardest, and who you will call before you use alone. Daily peer group meetings put you with people on the same clock, and the weekly family Zoom group gives your people their own place to learn why "just quit" does not work.

3. Weekly check-ins through the long stretch

Weeks three through twelve are where people coming off fentanyl quietly stop: the medication is working and the flatness and old routines are still there. Your coach shows up every week, and the lab-confirmed saliva screening turns "I think she's doing okay" into a shared record that you control. When a return to use happens, we treat it as information. The plan changes, the support goes up, and because tolerance drops so quickly, we talk directly about never using alone. Every coach at Accountable has their own recovery behind them, many through opioids specifically.

Accountable is covered by a growing list of commercial health plans, with more added each month, and private-pay plans start at $375 per month. You can check your coverage in a few minutes or call the care team at (646) 450-7641. Families are welcome to make the first call; see our page for families.

Common questions

How long does fentanyl stay in your system?

The injectable form's terminal half-life is 219 minutes (FDA prescribing information). With heavy daily use the drug stores in fat and clears slowly, averaging about seven days in people with opioid use disorder (Thakrar et al., 2024). Standard opiate tests do not detect it (ACMT).

How long does fentanyl withdrawal last?

Symptoms usually start within a day, often within hours, peak over days one to three, and ease over the following week (WHO). Heavy daily users often have lingering symptoms for two weeks or more.

Why did Suboxone make me feel worse?

Most likely precipitated withdrawal. Buprenorphine can knock fentanyl off the receptor and trigger sudden, severe withdrawal, and "The higher the level of physical dependence, the higher the likelihood of precipitating withdrawal" (SAMHSA TIP 63). Fentanyl stored in fat makes the usual 12-hour wait unreliable; in one hospital study it happened to 16.3 percent of fentanyl users (JAMA Network Open, 2024). A prescriber who knows it was fentanyl can adjust the induction.

How many overdose deaths involve fentanyl?

Deaths involving synthetic opioids other than methadone, mostly illicit fentanyl, numbered 72,776 in 2023 and fell to 47,735 in 2024, a 35.6 percent drop and the largest decline of any drug category (CDC NCHS Data Brief 549, 2026). That is still more than 130 deaths a day.

What should I do if someone on fentanyl will not wake up?

Call 911, give naloxone, and put them on their side. If there is no response after 2 to 3 minutes, give a second dose (SAMHSA). Give it even if you suspect xylazine; it will not touch the xylazine but it reverses the fentanyl underneath (CDC). Stay until help arrives; naloxone can wear off before the fentanyl does.

Sources

• Drug Enforcement Administration. Fentanyl drug fact sheet.

• Drug Enforcement Administration, Diversion Control Division. Fentanyl, drug and chemical information sheet, December 2025.

• Drug Enforcement Administration. One Pill Can Kill.

• Drug Enforcement Administration. One Pill Can Kill, Get Smart About Drugs, updated November 18, 2025.

• Drug Enforcement Administration, Office of Forensic Sciences. Fentanyl Profiling Program Annual Report, CY 2023. PRB-2025-017.

• Drug Enforcement Administration. DEA Releases 2025 National Drug Threat Assessment. Press release, May 15, 2025.

• Centers for Disease Control and Prevention. Fentanyl. Overdose Prevention, June 9, 2025.

• Centers for Disease Control and Prevention. Fentanyl Facts. Stop Overdose, April 2, 2024.

• Centers for Disease Control and Prevention. What You Should Know About Xylazine. Overdose Prevention, May 16, 2024.

• National Center for Health Statistics. Drug Overdose Deaths in the United States, 2023-2024. NCHS Data Brief No. 549, January 2026.

• U.S. Food and Drug Administration. Duragesic (fentanyl transdermal system), prescribing information, revised September 2018.

• U.S. Food and Drug Administration. Fentanyl citrate injection, prescribing information, revised December 2025.

• U.S. Food and Drug Administration. Suboxone (buprenorphine and naloxone) sublingual film, prescribing information, revised December 2025.

• U.S. Food and Drug Administration. FDA Approves First Over-the-Counter Naloxone Nasal Spray. Press announcement, March 29, 2023.

• Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder, Part 1: Introduction to Medications for Opioid Use Disorder Treatment. 2021 update, NCBI Bookshelf.

• Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder, Chapter 3D: Buprenorphine. 2021 update, NCBI Bookshelf.

• Substance Abuse and Mental Health Services Administration. Overdose Prevention and Response Toolkit. PEP23-03-00-001, 2023.

• American Society of Addiction Medicine. The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update.

• World Health Organization. Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings. 2009, NCBI Bookshelf.

• Thakrar AP, Christine PJ, Siaw-Asamoah A, et al. Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl. JAMA Network Open. 2024;7(9):e2435895.

• Stolbach AI, Connors NJ, Nelson LS, Kulig K. ACMT Practice Statement: Interpretation of Urine Opiate and Opioid Tests. American College of Medical Toxicology, September 13, 2021.